Abata Therapeutics
Transforming lives with Treg therapies
2 employees · est. 2021 · Watertown, United States
TRexBio
Decoding Human Tissue Biology to Create Revolutionary Therapeutics
62 employees · est. 2018 · South San Francisco, United...
TRexBio is the older company (2021 vs 2018); TRexBio is the larger of the two.
1 signal in the last 90 days
Side-by-Side Comparison
| Metric | Abata Therapeutics | TRexBio |
|---|---|---|
| Founded | ||
| Founded | 2021 | 2018 older |
| Headquarters | ||
| Headquarters | Watertown, United States | South San Francisco, United States |
| Employees | ||
| Employees | 2 | 62 larger |
| Industry | ||
| Industry | Biotechnology, Health and Wellness, Pharmaceutical | Biopharma, Biotechnology, Clean Energy |
| Funding Stage | ||
| Funding Stage | Unknown | Unknown |
| Total Funding | ||
| Total Funding | $190.00M | $219.00M |
| Funding Rounds | ||
| Funding Rounds | 3 | 6 |
| Services | ||
| Services | Not tracked yet | Development of biologics targeting immune balance, Decoding regulatory T cell behavior in human tissue, Creation of tissue-specific therapeutics |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with autoimmune diseases, Patients with inflammatory conditions, Healthcare providers in dermatology and gastroenterology |
| Taxonomy | ||
| Taxonomy | Not tracked yet | Clinical-stage, Immunoregulatory Medicines, Tissue Biology, Computational Biology, Human Tissue Focus, Immunobiology Expertise, Treg Behavior Mapping, Novel Targets Identification, Therapeutic Intervention, TNFR2-selective Agonist, Effector Tregs Activation, Inflammatory Diseases, Atopic Dermatitis, Immune Homeostasis Restoration |
| Website | ||
| Website | abatatx.com | trex.bio |
About Abata Therapeutics
Abata Therapeutics is a clinical-stage biotech company focused on developing Treg therapies for severe autoimmune and inflammatory diseases. Established in 2021, the company's expertise lies in Treg biology, TCR and antigen discovery, disease pathogenesis, and molecular and imaging biomarkers. Abata...
About TRexBio
TRexBio is a clinical-stage biotechnology company that is focused on developing immunoregulatory medicines. Founded in 2018 and headquartered in South San Francisco, California, the company is pioneering advances in tissue Treg biology to combat inflammatory diseases. Their commitment to decoding hu...
We will tell you when either one moves
BounceWatch watches Abata Therapeutics and TRexBio for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Abata Therapeutics and TRexBio — by email.
Frequently Asked Questions
Compare Abata Therapeutics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Abata Therapeutics on 9 Jun 2026, and TRexBio on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.